Clinical trials

  • (3S,6S,9S,12R,15S,18S,21S,24S,30S,33S,34R)-30-ETHYL-34-[(E,2R)-HEX-4-EN-2-YL]-4,7,10,12,15,19,25,28-OCTAMETHYL-33-(METHYLAMINO)-6,9,18,24-TETRAKIS(2-METHYLPROPYL)-3,21-DI(PROPAN-2-YL)-1-OXA-4,7,10,13,16,19,22,25,28,31-DECAZACYCLOTETRATRIACONTANE-2,5,8,11,14,17,20,23,26,29,32-UNDECONE HYDROCHLORIDE for Atopic keratoconjunctivitis
  • VAREGACESTAT for Desmoid tumour|Aggressive fibromatosis
  • ISOPRENALINE HYDROCHLORIDE for Cardiac arrest
  • Paclitaxel (albumin-bound) for Pancreatic ductal adenocarcinoma
  • bevacizumab for Metastatic colorectal cancer|Colorectal cancer
  • THIOPENTAL SODIUM for Neonatal general anaesthesia
  • 2-(6-[18F]FLUORO-PYRIDIN-3-YL)-9H-DIPYRIDO[2,3-B:3',4'-D]PYRROLE for Alzheimer's disease
  • orforglipron for Obstructive sleep apnea | Overweight or obesity
  • (12M)-(1S,2S)-N-((63S,4S,Z)-11-ETHYL-12-(2-((S)-1-METHOXYETHYL)-5-(4-METHYLPIPERAZIN-1-YL)PYRIDIN-3-YL)-10,10-DIMETHYL-5,7-DIOXO-61,62,63,64,65,66-HEXAHYDRO-11H-8-OXA-2(4,2)-THIAZOLA-1(5,3)-INDOLA-6(1,3)-PYRIDAZINACYCLOUNDECAPHANE-4-YL)-2-METHYLCYCLOPROPANE-1-CARBOXAMIDE for Metastatic pancreatic ductal adenocarcinoma
  • DALTEPARIN SODIUM for Acute critical illness
  • ATROPINE SULFATE MONOHYDRATE for Myopia
  • ISATUXIMAB for Multiple myeloma | Relapsed multiple myeloma after one prior line containing lenalidomide and a proteasome inhibitor